Skip Navigation LinksHome > July 2012 - Volume 31 - Issue 7 > Survival Benefit of Early Infant Antiretroviral Therapy is C...
Pediatric Infectious Disease Journal:
doi: 10.1097/INF.0b013e3182587796
HIV Reports

Survival Benefit of Early Infant Antiretroviral Therapy is Compromised When Diagnosis is Delayed

Wamalwa, Dalton MBChB, MPH, MMed Paed*; Benki-Nugent, Sarah MS, PhD; Langat, Agnes MBChB, MMed Paed*; Tapia, Ken MS; Ngugi, Evelyn MBChB*; Slyker, Jennifer A. PhD; Richardson, Barbra A. PhD§‡¶; John-Stewart, Grace C. MD, PhD

Supplemental Author Material
Collapse Box


Late presentation is common among African HIV-1–infected infants. Incidence and correlates of mortality were examined in 99 infants with HIV-1 diagnosis by 5 months of age. Twelve-month survival was 66.8% (95% confidence interval: 55.9–75.6%). World Health Organization stage 3 or 4, underweight, wasting, microcephaly, low hemoglobin, pneumonia and gastroenteritis predicted mortality. Early HIV-1 diagnosis with antiretroviral therapy before symptomatic disease is critical for infant survival.

© 2012 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.